NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $1.34 and traded as low as $0.87. NovaBay Pharmaceuticals shares last traded at $0.91, with a volume of 121,109 shares changing hands.
NovaBay Pharmaceuticals Price Performance
The business has a fifty day moving average price of $1.34 and a 200 day moving average price of $1.06. The company has a market capitalization of $5.47 million, a price-to-earnings ratio of -0.09 and a beta of 0.62.
NovaBay Pharmaceuticals Announces Dividend
The firm also recently declared a dividend, which was paid on Monday, September 29th. Shareholders of record on Wednesday, October 1st were paid a dividend of $0.80 per share. The ex-dividend date was Tuesday, September 30th. This represents a yield of 3,791.0%.
Institutional Investors Weigh In On NovaBay Pharmaceuticals
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Read More
- Five stocks we like better than NovaBay Pharmaceuticals
- How to Read Stock Charts for Beginners
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- What is diluted earnings per share (Diluted EPS)?
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- Consumer Staples Stocks, Explained
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
